TMCnet News
Century Health and Eye Health America to Unlock a Decade of Real-World Data to Advance Chronic Retinal Disease Research
NEW YORK, Sept. 15, 2026 /PRNewswire/ -- Century Health, a pioneer in applying AI to real-world clinical data to accelerate research, and Eye Health America (EHA), a leading integrated eye care platform in the Southeastern United States, today announced a partnership to transform years of clinical data into research-grade datasets that support real-world evidence generation and life sciences research for chronic retinal conditions, including diabetic retinopathy and age-related macular degeneration (AMD).
Ophthalmology is one of the most quantitative fields in medicine, requiring highly precise, individualized, longitudinal data. But disease progression measurements are generally trapped inside PDF attachments and scanned reports rather than entered into the EHR as structured data. As a result, studies, which typically rely only on structured EHR fields, miss critical aspects of the clinical picture. This leaves drug developers and clinicians with an incomplete view of how these diseases actually progress and how patients respond to treatment in routine care. These ongoing progression measurements are critical for the treatment of diabetic retinopathy and AMD. Both conditions are chronic and progressive, requiring years of monitoring and treatment to preserve vision, and affect a significant and growing share of Americans. An estimated 9.6 million people with diabetes live with diabetic retinopathy, including nearly 1.84 million with a vision-threatening form of the disease. AMD affects an estimated 19.8 million people, with prevalence rising sharply after ae 65. Response to therapy varies widely, and treatment decisions often depend on subtle changes in retinal structure over time rather than at diagnosis. The Century Health Abstraction and Retrieval Model, CHARM, will enable EHA to use these unstructured reports, some going back more than 10 years, to extract key values for quantitative retinal measurements and disease progression metrics. CHARM converts this historical, otherwise inaccessible data into structured datasets for research. Drawing on more than 200,000 de-identified records, the partnership will create one of the most detailed longitudinal datasets on chronic retinal disease available for research, supporting life sciences research into how these conditions respond to real-world variables. "Caring for patients with chronic eye conditions means following subtle changes over many years, yet much of that longitudinal history isn't available for large-scale research," said Dr. Cathleen McCabe, Chief Medical Officer at Eye Health America. "By transforming more clinical history into usable data, we can better understand how these diseases progress, identify which treatments work best for different patients, and ultimately improve the care we deliver." "The clinical data that matters most in retinal disease, like progression measurements, imaging findings, treatment response over years, has remained locked inside ophthalmology practices. We're thrilled to partner with Eye Health America to change that, and to bring this depth of real-world evidence to life sciences researchers," said Vish Srivastava, Co-Founder and CEO of Century Health. About Eye Health America About Century Health Media Contact
SOURCE Century Health
|
